Validation of a novel point of care testing device for sickle cell disease

2015115 citationsJournal Articlegold Open Access

Authors

Julie Kanter · Medical University of South Carolina

Marilyn J. Telen · Duke Medical Center

Carolyn Hoppe

Christopher L. Roberts · BioMedomics (United States)

Jason Kim · BioMedomics (United States)

Xiaoxi Yang · BioMedomics (United States)

Abstract

The Sickle SCAN™ test has the potential to significantly impact the diagnosis and treatment for sickle cell disease worldwide as well as enhance genetic counseling at the point of care. Further validation testing will be conducted in newborns in resource-poor settings in upcoming studies.

Topics & Keywords

Hemoglobinopathies and Related Disorders Iron Metabolism and Disorders Blood groups and transfusion

UN Sustainable Development Goals

No poverty

Publication Details

Published in: BMC Medicine

Volume 13, Issue 1, pp. 225-225

DOI: 10.1186/s12916-015-0473-6

Field-Weighted Citation Impact: 5.54